Entheogen Resurgence

Psychedelic Experiences Clinical Trial

— SERPNTS  

Official title:

Entheogen Resurgence - Surveying Entheogen Retreat Participants in Naturalistic Settings

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05042765
• Other study ID #: #2021-61137
• Status: Completed
• Start date: September 16, 2021
• Est. completion date: January 12, 2022

Study information

• Verified date: January 2022
• Source: Vireo Health
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

For the purpose of this anonymous, observational pilot survey, the investigators will define "entheogens" as substances, generally derived from plants, that are ingested in order to impact one's consciousness for therapeutic, religious, or spiritual purposes. This survey will focus on the naturalistic use of entheogens and other substances including kambo, ayahuasca, hapé, bufo, and sananga typically used in specific cultural and spiritual contexts for healing. There are substantial limitations to what the healthcare community knows about the intentions, motivations, experiences, health behaviors, and demographics of people who decide to participate in entheogen therapy centers or retreats and their willingness to participate in future research studies. The primary goal of this observational pilot survey is to collect self-reported, anonymous data from people who have opted to participate in entheogen therapy centers and retreats during the last five (5) years on the topics of their initial intentions, motivations, experiences, demographics, and willingness to participate in future entheogen research. With the support of established therapy and retreat centers, the research team will aim to collect 100 survey responses from unique, unidentified individuals who have participated in some form of entheogen therapy or treatment during the last five (5) years. Those who choose to fill out the survey will be at least 18 years of age, fluent in English, and self-reporting participation in therapy or a retreat which utilized entheogens in a naturalistic setting in the past five (5) years.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 102
• Est. completion date: January 12, 2022
• Est. primary completion date: January 12, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• >18 years old
• Fluent in English
• Self-reported participation in therapy or a retreat in a naturalistic setting that incorporated the use of entheogens in the past five (5) years

Exclusion Criteria:

• Inability to provide informed consent
• Inability to complete the online questionnaire
• No self-reported participation in therapy or a retreat in a naturalistic setting that incorporated the use of entheogens in the past five (5) years
• Self-reported participation in therapy or a retreat in naturalistic setting that incorporated the use of entheogens greater than five (5) years ago

Related Conditions & MeSH terms

• Psychedelic Experiences

Intervention

Other:
• self-reported entheogen use
self-reported participation in therapy or a retreat in a naturalistic setting that incorporated the use of entheogens in the past five (5) years

Locations

Country	Name	City	State
United States	Vireo Health of New York	Queens	New York

Sponsors (1)

Lead Sponsor	Collaborator
Vireo Health

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Entheogen Use in Naturalistic Retreat & Therapeutic Settings	The primary outcome will be self-reported experiences related to entheogen use in naturalistic retreat and therapeutic settings.	Entheogen use will have occured within the last 5 years